Literature DB >> 17981603

Regulation of NK cell activity by 2B4, NTB-A and CRACC.

Maren Claus1, Stephan Meinke, Rauf Bhat, Carsten Watzl.   

Abstract

2B4, NTB-A and CRACC are members of the recently defined family of SLAM-related receptors. Here we review the role of these receptors for the regulation of Natural Killer cell function and describe the current knowledge about the signal transduction of these receptors. Finally, we critically analyze some controversial data about the function of 2B4 in mouse and man.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 17981603     DOI： 10.2741/2735

Source DB:  PubMed          Journal:  Front Biosci        ISSN： 1093-4715


  21 in total

Review 1.  Clinical utility of natural killer cells in cancer therapy and transplantation.

Authors:  David A Knorr; Veronika Bachanova; Michael R Verneris; Jeffrey S Miller
Journal:  Semin Immunol       Date:  2014-03-05       Impact factor: 11.130

Review 2.  NK cells and their ability to modulate T cells during virus infections.

Authors:  Kevin D Cook; Stephen N Waggoner; Jason K Whitmire
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

Review 3.  Signal transduction during activation and inhibition of natural killer cells.

Authors:  Carsten Watzl; Eric O Long
Journal:  Curr Protoc Immunol       Date:  2010-08

Review 4.  Optimizing intracellular signaling domains for CAR NK cells in HIV immunotherapy: a comprehensive review.

Authors:  Giorgio Zenere; Omalla Allan Olwenyi; Siddappa N Byrareddy; Stephen E Braun
Journal:  Drug Discov Today       Date:  2019-02-13       Impact factor: 7.851

5.  Glycosylation affects ligand binding and function of the activating natural killer cell receptor 2B4 (CD244) protein.

Authors:  Stefanie Margraf-Schönfeld; Carolin Böhm; Carsten Watzl
Journal:  J Biol Chem       Date:  2011-05-23       Impact factor: 5.157

Review 6.  SLAM receptors and SAP influence lymphocyte interactions, development and function.

Authors:  Pamela L Schwartzberg; Kristen L Mueller; Hai Qi; Jennifer L Cannons
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

7.  Role of the NK cell-activating receptor CRACC in periodontitis.

Authors:  Benjamin Krämer; Moritz Kebschull; Michael Nowak; Ryan T Demmer; Manuela Haupt; Christian Körner; Sven Perner; Søren Jepsen; Jacob Nattermann; Panos N Papapanou
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

Review 8.  The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT).

Authors:  Bree Foley; Martin Felices; Frank Cichocki; Sarah Cooley; Michael R Verneris; Jeffrey S Miller
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

Review 9.  NK cell therapy for hematologic malignancies.

Authors:  Rohtesh S Mehta; Brion Randolph; May Daher; Katayoun Rezvani
Journal:  Int J Hematol       Date:  2018-01-27       Impact factor: 2.490

10.  Differential loss of natural killer cell activity in patients with acute myocardial infarction and stable angina pectoris.

Authors:  Wenwen Yan; Lin Zhou; Siwan Wen; Qianglin Duan; Feifei Huang; Yu Tang; Xiaohong Liu; Yongyan Chai; Lemin Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.